Novo Nordisk's stocks face YTD struggles due to trial results and tariffs, but strong fundamentals and outlook justify a Buy.

Once-weekly basal insulin combined with an intermittently scanned continuous glucose monitor reduced HbA1c and improved time ...

Drugmaker Eli Lilly said Thursday that an experimental pill form of popular GLP-1 medications helped people with type 2 ...

Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable ...

There's no doubt that self-injection devices have transformed the lives of people with chronic diseases like diabetes ... range of items, such as chairs, lamps, and other glassware. "Novo Nordisk ...

for the treatment of diabetes and obesity. In 2018, Stephen became senior vice president and global chief medical officer. Prior to joining Novo Nordisk, Stephen was Head of the Oxford Centre for ...

Eli Lilly said its new weight-loss pill had cleared a late-stage clinical trial, a promising sign as the company continues to ...

In 2020, the US Food and Drug Administration approved Novo Nordisk’s Rybelsus for treatment ... insulin, a hormone the pancreas makes to help the body keep blood sugar levels in a certain range.